Plain-English translation of NCT07542041 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new technology called the ARTIDIS ART-1 system, which uses advanced microscopy to measure the physical properties of pancreatic cancer tissue samples. Researchers want to understand whether these measurements can help predict how well patients will respond to cancer treatment, especially chemotherapy given before surgery. The goal is to find a better way to understand pancreatic cancer behavior and guide treatment decisions.
Pancreatic cancer is often diagnosed late, spreads quickly, and doesn't always respond well to standard treatments. Doctors need better tools to understand each patient's cancer and predict which treatments will work best, so this study is testing whether analyzing tissue properties can provide that insight.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo your standard biopsy or surgery as planned. During that procedure, doctors would collect one additional small tissue sample for research purposes — this doesn't change your regular care or delay treatment. That sample would be analyzed using the new ARTIDIS technology before being sent to the lab for routine testing. Researchers would then follow your medical information, imaging results, and treatment outcomes over time to see how the tissue measurements relate to how you respond to therapy.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States
Sponsor
ARTIDIS AG
Collaborators
H. Lee Moffitt Cancer Center and Research Institute
Enrollment target
~200 participants
Started
April 2026
Primary completion
May 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Julia Ortega, DMSc, MHS, PA
ARTIDIS AG
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.